This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VIG
Humana (HUM) Q2 Earnings Beat Estimates, Ups '22 EPS View
by Zacks Equity Research
Humana's (HUM) second-quarter earnings benefit from higher premiums and strong individual Medicare Advantage membership growth. A hiked adjusted EPS guidance for 2022 is noteworthy.
Is First Trust Rising Dividend Achievers ETF (RDVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RDVY
Universal Health (UHS) Q2 Earnings Beat on Strong Segments
by Zacks Equity Research
Universal Health's (UHS) second-quarter results benefit from strong contributions from Acute Care Hospital Services and Behavioral Health Care Services segments, partly offset by elevated operating costs.
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VTV
Tenet Healthcare (THC) Q2 Earnings Beat, Trims '22 EPS View
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter earnings benefit from strong Ambulatory Care and Conifer segments. However, a trimmed EPS view for 2022 might raise concerns for investors.
HCA Healthcare (HCA) Q2 Earnings Beat on Better Patient Volumes
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results reflect improved revenues stemming from better same-facility emergency room visits. However, the results were partly offset by elevated salaries and benefits cost.
The Zacks Analyst Blog Highlights Tesla, Chevron, Exxon Mobil, Broadcom and UnitedHealth Group
by Zacks Equity Research
Tesla, Chevron, Exxon Mobil, Broadcom and UnitedHealth Group have been included in this Analyst Blog.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
Here's Why UnitedHealth Group (UNH) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does UnitedHealth Group (UNH) have what it takes to be a top stock pick for momentum investors? Let's find out.
If You Invested $1000 in UnitedHealth Group 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
July Rally May Indicate the Peak of U.S. Inflation: 5 Picks
by Nalak Das
We have narrowed our search to five U.S. corporate bigwigs with strong potential for the rest of 2022. These are: TSLA, UNH, CVX, XOM and AVGO.
Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
The Zacks Analyst Blog Highlights Apple, UnitedHealth Group, Equinor, GSK and Eaton
by Zacks Equity Research
Apple, UnitedHealth Group, Equinor, GSK and Eaton have been included in this Analyst Blog.
Top Analyst Reports for Apple, UnitedHealth, Equinor & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), UnitedHealth Group Incorporated (UNH), and Equinor ASA (EQNR).
ETFs to Buy on UnitedHealth's Q2 Earnings Beat
by Sweta Killa
UnitedHealth reported better-than-expected second-quarter 2022 results, breezing past the Zacks Consensus Estimate for both earnings and revenues. The company lifted its full-year earnings guidance for the second straight quarter.
Company News for Jul 18, 2022
by Zacks Equity Research
Companies in The News Are: UNH,USB,BK,PNC
UnitedHealth Group (UNH) Q2 Earnings Beat, Hikes '22 EPS View
by Zacks Equity Research
UnitedHealth Group's (UNH) second-quarter results gain from revenue growth stemming from solid segmental contributions and membership growth. A raised 2022 EPS view remains noteworthy.
UnitedHealth Group (UNH) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 6.30% and 0.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is UnitedHealth Group (UNH) a Buy Heading into Q2 Earnings Announcement?
by Bryan Hayes
With a robust history of exceeding earnings estimates, is another beat in store for UNH investors?
Stock Market News for Jul 14, 2022
by Zacks Equity Research
Wall Street closed lower on Wednesday after a key inflation data for June came in at a 41-year high.
UnitedHealth Q2 Preview: Can the Earnings Streak Continue?
by Derek Lewis
Undoubtedly impressive, UNH has reported strong bottom-line results consistently, exceeding the Zacks Consensus EPS Estimate in each of its last 30 quarterly reports.
Centene (CNC) Wins Contract to Serve Delaware's Medicaid Members
by Zacks Equity Research
Centene's (CNC) Delaware subsidiary receives a contract from the State of Delaware's DHSS to efficiently serve the diversified health needs of the state's Medicaid members.
UnitedHealth (UNH) to Post Q2 Earnings: What to Expect?
by Zacks Equity Research
UnitedHealth Group's (UNH) second-quarter results are likely to reflect improving premiums, products and higher expenses.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF